Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

IFN-γ

  • You have access
    STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer
    HIROTAKA FUCHIZAWA, KIYOHIRO ANDO, NORIKO MOTOI, TOSHIHIKO IIZUKA, MASAHARU INOUE, KOUKI MITANI, YUTA SANO, HISANORI TAKENOBU, MASAYUKI HARUTA, RITSUKO ONUKI, YOH MATSUOKA, TAKEHIKO KAMIJO and YUKIO KAGEYAMA
    Anticancer Research May 2024, 44 (5) 1925-1930; DOI: https://doi.org/10.21873/anticanres.16994
  • You have access
    High STAT4 Expression Indicates Better Disease-free Survival in Patients with Gastric Cancer
    MASAAKI NISHI, BAT-ERDENE BATSAIKHAN, KOZO YOSHIKAWA, JUN HIGASHIJIMA, TAKUYA TOKUNAGA, CHIE TAKASU, HIDEYA KASHIHARA, DAICHI ISHIKAWA and MITSUO SHIMADA
    Anticancer Research December 2017, 37 (12) 6723-6729;
  • You have access
    Uterine Leiomyosarcoma Tumorigenesis in Lmp2-deficient Mice: Involvement of Impaired Anti-oncogenic Factor IRF1
    TAKUMA HAYASHI, AKIKO HORIUCHI, KENJI SANO, NOBUO YAEGASHI and IKUO KONISHI
    Anticancer Research September 2015, 35 (9) 4665-4679;
  • You have access
    Immunogenic Modulation of Cholangiocarcinoma Cells by Chemoimmunotherapy
    SHIGEO KOIDO, SHIN KAN, KOSAKU YOSHIDA, SHINJI YOSHIZAKI, KAZUKI TAKAKURA, YOSHIHISA NAMIKI, SHINTARO TSUKINAGA, SHUNICHI ODAHARA, MIKIO KAJIHARA, MASATO OKAMOTO, MASAKI ITO, SEI-ICHI YUSA, JIANLIN GONG, HARUO SUGIYAMA, TOSHIFUMI OHKUSA, SADAMU HOMMA and HISAO TAJIRI
    Anticancer Research November 2014, 34 (11) 6353-6361;
  • You have access
    Establishment and Evaluation of a Bead-based Luminex Assay Allowing Simultaneous Quantification of Equine IL-12 and IFN-γ
    MARIA CAROLINA DURAN, SASKIA WILLENBROCK, JESSIKA-M. V. MÜLLER, INGO NOLTE, KARSTEN FEIGE and HUGO MURUA ESCOBAR
    Anticancer Research April 2013, 33 (4) 1325-1336;
  • You have access
    RNA Interference with EAG1 Enhances Interferon Gamma Injury to Glioma Cells In Vitro
    LUDMYLLA COSTA CUNHA, ELAINE DEL BEL, LUIS PARDO, WALTER STÜHMER and RICARDO TITZE-DE-ALMEIDA
    Anticancer Research March 2013, 33 (3) 865-870;
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire